Dapiprazole
From Wikipedia, the free encyclopedia
Not to be confused with Aripiprazole.
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8- tetrahydro-[1,2,4]triazolo[4,5-a]pyridine |
|
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a601043 |
| Pregnancy cat. | B |
| Legal status | ℞ Prescription only |
| Routes | Topical (eye drops) |
| Pharmacokinetic data | |
| Bioavailability | Negligible when administered topically |
| Identifiers | |
| CAS number | 72822-12-9  |
| ATC code | S01EX02 |
| PubChem | CID 3033538 |
| DrugBank | APRD00902 |
| ChemSpider | 2298190 |
| UNII | 5RNZ8GJO7K |
| KEGG | D07775 |
| ChEBI | CHEBI:51066 |
| ChEMBL | CHEMBL1201216  |
| Chemical data | |
| Formula | C19H27N5 |
| Mol. mass | 325.451 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Dapiprazole (Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.
[edit] References
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (March 2010) |
|
|
 |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
